Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-15

Clinical Trial Update: Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations [Phase 2]

View source ↗

Summary

Phase 2 trial updating activity of molecularly matched targeted therapies across select tumor types based on genomic alterations; study completed with posted re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Non-small Cell Lung Carcinoma, Urothelial Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2023-09-15